Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 535-538

  Wolf, Dana G ^a   Yaniv, Isaac ^b   Honigman, Alik ^b   Kassis, Imad ^b   Schonfeld, Tommy ^b   Ashkenazi, Shai ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA REPAIR; GENE MUTATION; HUMAN; INFANT; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS GENE;

EID: 0031848922     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517468     Document Type: Article

References (15)

1. Christenson JC, Hill HR. Infections complicating congenital immunodeficiency syndromes. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. 3rd ed. New York: Plenum Medical Book, 1994:521-49.
2. Crumpacker CS. Ganciclovir. N Engl J Med 1996; 335:721-9.
3. Drew WL, Miner RC, Busch DF, et al. Prevalence of CMV resistance in patients receiving ganciclovir for serious CMV infection. J Infect Dis 1991; 163:716-9.
4. Wolf DG, Smith IL, Lee DJ, Freeman WR, Flores-Aguilar M, Spector SA. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest 1995; 95:257-63.
5. Chou S, Erice A, Jordan MC, at al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171:576-83.
6. Rosen HR, Benner KG, Flora KD, et al. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation 1997; 63:476-8.
7. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992; 358:162-4.
8. Lurain N, Spafford LE, Thompson KD. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol 1994; 68:4427-31.
9. Rosen FS, Wedgwood RJP, Eibl M, et al. Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol 1995; 1(suppl 99):1-24.
10. Chou S, Dennison K. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163:1229-34.
11. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995; 172:239-42.
12. Chou S, Marousek G, Guentzel S, et al. Evaluation of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J Infect Dis 1997; 176:786-9.
13. Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39:2252-4.
14. Fischer A. Primary T cell immunodeficiencies. Curr Opin Immunol 1993; 5:569-78.
15. Cavazzana-Calvo M, Le Deist F, De Saint Basile G, Papadopoulo D, De Villartay JP, Fischer A. Increased radiosensitivity of granulocyte macrophage colony forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J Clin Invest 1993; 91:1214-8.